| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
group | 0.090 | None | 0.889 | 9 | 0 | 2017 | 2019 | |||||||||
|
IgA nephropathy | 0.524 | 0.808 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2009 | 2020 | |||||||||
|
PGR antisense RNA 1 | 0.514 | 0.808 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2018 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2018 | 2019 | |||||||||
|
platelet and endothelial cell adhesion molecule 1 | 0.426 | 0.846 |
|
group | 0.040 | None | 1.000 | 4 | 3 | 2009 | 2019 | |||||||||
|
PPP1R2C family member C | 0.478 | 0.846 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2016 | 2019 | |||||||||
|
diabetic nephropathy | 0.678 | 0.500 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2019 | |||||||||
|
microRNA 214 | 0.480 | 0.808 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2019 | |||||||||
|
microRNA 223 | 0.433 | 0.808 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | |||||||||
|
suppression of tumorigenicity 2 | 0.576 | 0.692 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2020 | |||||||||
|
adenosylmethionine decarboxylase 1 pseudogene 2 | 0.608 | 0.538 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | |||||||||
|
microRNA 145 | 0.431 | 0.846 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2017 | |||||||||
|
microRNA 150 | 0.455 | 0.808 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2019 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2017 | |||||||||
|
microRNA 17 | 0.459 | 0.846 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
microRNA 29b-1 | 0.485 | 0.846 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | |||||||||
|
microRNA 29b-2 | 0.484 | 0.885 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | |||||||||
|
microRNA 30b | 0.555 | 0.808 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2020 | |||||||||
|
neutrophil migration | 0.473 | 0.808 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
basic transcription factor 3 pseudogene 11 | 0.519 | 0.731 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | |||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 963 | 0.700 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
TMX2-CTNND1 readthrough (NMD candidate) | 0.538 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |